Suppr超能文献

促甲状腺激素和催乳素分泌型垂体瘤对溴隐亭的激素反应分离。

Thyrotropin-and prolactin--secreting pituitary tumor dissociated hormonal response to bromocriptine.

作者信息

Jap T S, Kwok C F, Ho L T

机构信息

Department of Medicine, Veterans General Hospital-Taipei, R.O.C.

出版信息

Zhonghua Yi Xue Za Zhi (Taipei). 1990 Mar;45(3):191-5.

PMID:2168264
Abstract

A 41-year-old male with recurrent hyperthyroidism resulting from pituitary tumor was studied. Because of recurrent hyperthyroidism, he had been treated with propylthiouracil for four years and had been operated. At the time of high serum thyroid hormone (T4: 20 micrograms/dl; T3:502 ng/dl), there was also elevated basal serum TSH level (55 microU/ml) which could not be suppressed by exogenous thyroid hormone administration. In addition, the serum TSH showed blunt response to intravenous TRH infusion. An elevated serum prolactin level was also observed (111 ng/ml). After bromocriptine administration (2.5 mg daily), the suppressibility of serum TSH level was found better than that of prolactin level. The existence of a TSH- and PRL-secreting pituitary tumor in this patient exhibited a dissociated hormonal response to low doses of dopaminergic agents.

摘要

对一名因垂体瘤导致复发性甲状腺功能亢进的41岁男性进行了研究。由于复发性甲状腺功能亢进,他接受丙硫氧嘧啶治疗四年并接受了手术。在血清甲状腺激素水平较高时(T4:20微克/分升;T3:502纳克/分升),基础血清促甲状腺激素(TSH)水平也升高(55微单位/毫升),且外源性甲状腺激素给药无法抑制该水平。此外,血清TSH对静脉注射促甲状腺激素释放激素(TRH)的反应迟钝。还观察到血清催乳素水平升高(111纳克/毫升)。给予溴隐亭(每日2.5毫克)后,发现血清TSH水平的抑制性优于催乳素水平。该患者存在分泌TSH和PRL的垂体瘤,对低剂量多巴胺能药物表现出激素反应分离。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验